Boston Scientific

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Boston Scientific 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BSX

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. 

CEO
Michael F. Mahoney
CEOMichael F. Mahoney
Employees
59,000
Employees59,000
Headquarters
Marlborough, Massachusetts
HeadquartersMarlborough, Massachusetts
Founded
1979
Founded1979
Employees
59,000
Employees59,000

BSX Key Statistics

Market cap
65.19B
Market cap65.19B
Price-Earnings ratio
19.38
Price-Earnings ratio19.38
Dividend yield
Dividend yield
Average volume
19.26M
Average volume19.26M
High today
$47.50
High today$47.50
Low today
$44.87
Low today$44.87
Open price
$47.43
Open price$47.43
Volume
28.96M
Volume28.96M
52 Week high
$109.50
52 Week high$109.50
52 Week low
$42.20
52 Week low$42.20

Stock Snapshot

The current Boston Scientific(BSX) stock price is $45.10, with a market capitalization of 65.19B. The stock trades at a price-to-earnings (P/E) ratio of 19.38.

On 2026-09-08, Boston Scientific(BSX) stock traded between a low of $44.87 and a high of $47.50. Shares are currently priced at $45.10, which is +0.5% above the low and -5.1% below the high.

The Boston Scientific(BSX)'s current trading volume is 28.96M, compared to an average daily volume of 19.26M.

During the past year, Boston Scientific(BSX) stock moved between $42.20 at its lowest and $109.50 at its peak.

During the past year, Boston Scientific(BSX) stock moved between $42.20 at its lowest and $109.50 at its peak.

BSX News

Benzinga 4h
Boston Scientific Says It Won't Meet 2026 Guidance After Cyberattack

Boston Scientific Corporation (NYSE:BSX) anticipates a material hit to its third-quarter and full-year 2026 financial results following an August cybersecurity...

Boston Scientific Says It Won't Meet 2026 Guidance After Cyberattack
The Wall Street Journal 5h
Boston Scientific Lowers Full-Year Targets After Cyberattack

Medical-device maker Boston Scientific said that it is unlikely to meet its sales growth and earnings expectations for the year, citing a major cyberattack disc...

Boston Scientific Lowers Full-Year Targets After Cyberattack
TipRanks 7h
Boston Scientific put volume heavy and directionally bearish

Bearish flow noted in Boston Scientific (BSX) with 14,699 puts trading, or 4x expected. Most active are Oct-26 40 puts and 9/11 weekly 46 puts, with total volum...

Analyst ratings

85%

of 33 ratings
Buy
84.8%
Hold
15.2%
Sell
0%

More BSX News

Investor's Business Daily 7h
Boston Scientific Slammed After Cyberattack Hamstrings Sales, Profit

Technology Boston Scientific Slammed After Cyberattack Hamstrings Sales, Profit Licensing Boston Scientific (BSX) said Tuesday an August cybersecurity incident...

Boston Scientific Slammed After Cyberattack Hamstrings Sales, Profit
Nasdaq 8h
Boston Scientific's 2026 Growth Outlook Weakens: Is Recovery Ahead?

Boston Scientific BSX has entered the second half of 2026 with more pressure than expected as weakness in two important businesses weighs on its near-term perfo...

Boston Scientific's 2026 Growth Outlook Weakens: Is Recovery Ahead?
TipRanks 10h
Boston Scientific Stock Slides as Cyberattack Set to Batter Full-Year Profits

Shares in medical technology group Boston Scientific (BSX) slumped nearly 3% in pre-market trading after it said that last month’s cyberattack on its business w...

TipRanks 10h
Boston Scientific: Buy Rating Reiterated as Watchman Outlook Normalizes; $54 Price Target Maintained

Analyst Travis Steed from Bank of America Securities maintained a Buy rating on Boston Scientific and keeping the price target at $54.00. Travis Steed has given...

Simply Wall St 2d
Is Boston Scientific Undervalued Following Recalls, Cyberattack, And Lower Guidance?

Boston Scientific (BSX) is under close watch after a cluster of company specific shocks. Recent voluntary global device recalls and an ongoing cyberattack relat...

Is Boston Scientific Undervalued Following Recalls, Cyberattack, And Lower Guidance?
TipRanks 4d
TD says Boston Scientific shipping update ‘big step forward’

TD Cowen highlights that Boston Scientific (BSX) yesterday said it has begun restoring shipping capabilities for the majority of its products at its major distr...

Benzinga 4d
Boston Scientific Recalls Spinal Cord Stimulator Leads Over Fracture Risk

Health authorities have categorized an urgent device withdrawal by Boston Scientific Corp. (NYSE:BSX) as the most serious class of recall available. Severe FDA...

Boston Scientific Recalls Spinal Cord Stimulator Leads Over Fracture Risk

People also own

Based on the portfolios of people who own BSX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.